研究目的
Investigating the potential utility of a fractionated CO2 laser to treat Dupuytren disease (DD), a treatment option that has not been described previously.
研究成果
The fractionated CO2 laser treatment showed promising results in improving mobility and extension in a patient with DD, suggesting a potential new treatment modality. Further studies are needed to explore its efficacy and mechanism of action.
研究不足
The study is limited by its single-case design, which may not be representative of all DD cases. Further research with a larger sample size is needed to validate the findings.
1：Experimental Design and Method Selection:
A case study was conducted on a 66-year-old male with DD, treated with a fractionated CO2 laser.
2：Sample Selection and Data Sources:
The patient had a 10-year history of untreated DD.
3：List of Experimental Equipment and Materials:
A fractionated 10,600-nm CO2 laser (Fraxel Re:Pair; Solta Medical) was used.
4：Experimental Procedures and Operational Workflow:
The patient underwent three laser treatments with specific settings and post-treatment care.
5：Data Analysis Methods:
Improvement in mobility and extension of the fingers was measured and reported.
独家科研数据包，助您复现前沿成果，加速创新突破
获取完整内容
